Nanoscale Advances, 2025 · DOI: 10.1039/d4na00885e · Published: January 7, 2025
Spinal cord injury leads to secondary tissue damage due to a decline in antioxidant enzymes and anti-inflammatory cytokines, causing permanent neural dysfunction. The spinal cord's high lipid content makes it vulnerable to oxidative injury from reactive oxygen species (ROS). Excessive ROS generation results in oxidative stress and increased free radicals, worsening secondary damage. Pyrroloquinoline quinone (PQQ) is a natural antioxidant with neuroprotective effects. The main challenge is delivering the drug to the target site effectively. Nanofibers are a promising tool for drug delivery in biomedical fields. This study investigates the use of PQQ loaded on coaxial nanofibers in an experimental model of spinal cord injury in rats. The nanofiber coaxial design protects drugs, ensuring they remain bioactive during release.
PQQ-loaded coaxial nanofibers may represent a promising therapeutic strategy for mitigating oxidative stress and improving outcomes following spinal cord injury.
The coaxial nanofiber drug delivery system shows promise for localized and sustained release of antioxidants in the injured spinal cord.
The study supports the use of biocompatible and biodegradable polymers like chitosan and PVA in creating effective scaffolds for tissue regeneration and drug delivery.